Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Serneke to build 160 rental apartments in Årsta

Serneke has today signed a turnkey contract with Stockholmshem regarding the construction of 160 homes in Årsta. The order is valued at approximately SEK 330 million.The project, located within the Sävlången 2 and Idlången 3 properties, is part of the so-called Årstastråket area, where the City of Stockholm plans to create some 3,000 new homes for 7,500 inhabitants over a period of at least ten years in a central and attractive location, with good access to public transport, recreation opportunities and services. In addition to housing, the contract includes a preschool with four

Resurs Bank examines the possibility to issue bonds within existing MTN-programme

Resurs Bank AB (Publ) has mandated Nordea and Swedbank for an expected SEK 500m 3 year senior unsecured transaction, under the issuers SEK 5bn MTN Programme. The transaction will follow after a fixed income investor presentation (breakfast) on 28 November in Stockholm, subject to market conditions. For additional information:Peter Rosén, CFO & Head of IR, peter.rosen@resurs.se  +46 736 56 49 34Sofie Tarring, IR-Officer, sofie.tarring@resurs.se +46 736 44 33 95    About Resurs Bank:Resurs was founded in 1977 and is one of the fastest-growing niche banks in the Nordic region.

InDex Pharmaceuticals Holding AB (publ) interim report January – September 2017

Strengthened patent protection for cobitolimodPeriod July – September 2017 ·  Revenues amounted to SEK 0.0 (0.0) million ·  Operating result amounted to SEK –13.3 (–6.6) million ·  Result after tax amounted to SEK –13.1 (–7.4) million, corresponding to SEK –0.21 per share (–0.25) before and after dilution ·  Cash flow from operating activities amounted to SEK –16.6 (–7.5) million  Period January – September 2017 ·  Revenues amounted to SEK 0.1 (0.1) million ·  Operating result amounted to SEK –50.7 (–23.2) million ·  Result after tax amounted to SEK –50.4 (–24.9)

Prestigious award to Polygon Norway

Polygon AS in Norway has been honored with the “Service Achievement of the Year 2017” award by NHO Service (The Confederation of Norwegian Enterprise in the Service Sector). The award was recently presented during NHO Service`s annual conference and was accepted by a very proud Kai Andersen, Country President for Polygon Norway.“It makes me very proud of being part of such an organisation as Polygon Norway. We are thrilled to get this award and it shows that all our work we have done has paid off”, says Kai Andersen, Country President at Polygon Norway. The jury’s motivation:“Polygon

Jon Shafer moves on from Paradox Interactive

In May this year Paradox Interactive announced it had hired award winning game developer Jon Shafer, to start a new project. Today Paradox and Shafer announced that they have decided to part ways due to creative differences.  "Jon is an ambitious person with a lot of drive and passion and he has led some good discussions in our teams over the past few months", said Mattias Lilja - Executive Vice President of Studios at Paradox Interactive. "However, during the course of these discussions, it has become clear that we want different things creatively and we have therefore taken the mutual

TECHSTEP ASA: Q3 2017 RESULTS

Highlights · Techstep has continued to execute its growth strategy by acquiring two additional companies, developing its “Mobile as a Service” offering, growing its end user base and solutions sales · Q3 2017 revenues of NOK 180.8 million (NOK 132.7 million) ; increase reflecting acquisitions made in the period, as well as 40% organic growth in solutions revenue · Adjusted EBITDA of NOK 9.8 million (NOK 4.1 million) and EBITDA margin of 5.4% (3.1%) ; reflects positive development in solutions sales, partly offset by growth investments · Surpassed 600,000 end users across

Viking Line: Business Review for the period January - September 2017

Viking Line Abp           BUSINESS REVIEW            17.11.2017, 9.00 AMBUSINESS REVIEW FOR THE PERIOD JANUARY–SEPTEMBER 2017 Consolidated sales of the Viking Line Group for the period January 1–September 30, 2017 rose to 399.6 million euros (EUR 397.3 M for January 1–September 30, 2016). Other operating revenue amounted to EUR 1.3 M (2.0). Operating income totalled EUR 6.3 M (14.8). Net financial items totalled EUR -1.7 M (-3.2). Consolidated income before taxes amounted to EUR 4.6 M (11.6). Income after taxes totalled EUR 3.8 M (9.7). Competition in Viking Line's service area

Hiddn Solutions ASA - Mandatory notification of trade

Reference is made to the announcement made on 16 November 2017 by Hiddn Solutions ASA (the "Company") in connection with a successfully private placement of NOK 7,500,000 million in new shares. Dallas Asset Management AS, a company controlled by Jan Opsahl, board member in the Company, has been allocated 1,000,000 shares in the Company. Following the completion of the private placement, Dallas Asset Management AS will hold 3,200,000 shares (4.29%) in the Company. Wollebekkgruppen AS, a company 50 % owned by Carl Espen Wollebekk, CEO, has been allocated 100,000 shares in the Company.

Planmeca CALM™ receives Innovation 2017 honorary mention

The dental industry Innovation award will once again be handed out at this month’s Finnish Dental Congress and Exhibition  in Helsinki, Finland. The award and accompanying honorary mentions are given to companies or associations which have developed a product, service or technology that has significantly improved treatment, patient safety or the working conditions of the dentist. The Planmeca CALM™ algorithm solves the challenge of movement artefacts in CBCT imaging The new Planmeca CALM™ algorithm has received the Innovation 2017

Ambea interim report January-September 2017

CEO comment: ”In the third quarter, we continued to see positive results from our strategy, which is to grow the number of our Own Management units both by opening new residential care units and through acquisitions. During the quarter, we opened two new LSS residential care units in Sweden one new unit in Norway, and completed one acquisition in each market. Our organic growth in Norway is proceeding well, but the weak tender market in Sweden and the supported living units that were closed down – and for which we are still awaiting permits – are posing a challenge. Net sales for the

Ambea repurchases own shares

The Board of Ambea AB (publ) has resolved to initiate a share buyback program for a total of 62,277 shares until May 22, 2018.Repurchased shares will be saved to be used under Ambea’s share savings plan. The buyback program will be managed by a securities company or credit institution that makes its trading decisions regarding Ambea’s shares independently of, and without influence by, Ambea with regard to the timing of the repurchases. The buyback program shall meet the following terms: 1. Repurchases of shares are to be made on Nasdaq Stockholm and in accordance with Nasdaq

Multiconsult ASA – Repurchase of own shares

On 16 November 2017, Multiconsult ASA ("Multiconsult") purchased 1 764 of its own shares at an average price of NOK 75.94 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 426 726 of its own shares.  For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no Media:      Gaute Christensen, VP

BerGenBio ASA: Results for the Third Quarter 2017

Bergen, Norway, 17 November 2017 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective Axl kinase inhibitors for multiple cancer indications, announces its results for the third quarter 2017. A presentation of the results by the Company’s senior management team will take place today at 9.00 am CET in Oslo – details below.Richard Godfrey, Chief Executive Officer of BerGenBio, commented: “We are very pleased with the progress the company has made during Q3 2017. Our broad clinical development programme of Phase 2 trials with BGB324, our

THQ Nordic acquires Biomutant® developer Experiment 101

THQ Nordic is today announcing that it has acquired the shares of Experiment 101 AB, a Swedish independent game developer, currently developing the critically acclaimed game Biomutant. The acquisition includes the development studio and all intellectual property rights to Biomutant.Biomutant is an open world, post-apocalyptic kung-fu fable action role-playing game. The game was first announced at Gamescom in August 2017, receiving strong reception with fans and the gaming media. The total consideration paid for all shares is SEK 75.3 million paid to the sellers Goodbye Kansas and Stefan

Ambea’s Quality Report for third quarter 2017

Since 2013, Ambea presents quarterly Quality Reports. The purpose is to continuously present relevant quality parameters, handling of deviations and external scrutiny. In the Quality Report for the third quarter 2017, among other things, several awards and nominations for awards are presented.”Rewards and awards stimulate to engagement and development in our operations. Therefore, both internal and external awards and rewards are of great importance. For example, Vardaga Österbo’s successful project for reducing unwanted effects of medical drugs is now nominated for two awards. That means

Brain astrocytes linked to Alzheimer’s disease

Astrocytes, the supporting cells of the brain, could play a significant role in the pathogenesis of Alzheimer’s disease (AD), according to a new study from the University of Eastern Finland. This is the first time researchers discovered a direct association between astrocytes and AD. Published in Stem Cell Reports, the study investigated the brain cell function of familial AD patients by using stem cell technologies. Alzheimer’s disease is the most common dementia type, with no treatment to slow down the progression of the disease currently available. The mechanisms of AD are poorly

Hiddn Solutions ASA – Share option program

The board of Hiddn Solutions ASA (“Hiddn” or the “Company”) has today on 16 November 2017 approved a share option program in the Company under which employees can be granted options to purchase shares in Hiddn on the terms and conditions applicable under the program. The share option program has been prepared in accordance with the board’s statement on remuneration to executive management for 2017 as well as the board authorization granted by the Company’s annual general meeting on 22 June 2017 to issue shares in the Company in connection with options granted to employees. Under the

Attana, Karoliniska Universitetssjukhuset and KTH receives project grant of 4.8 MSEK

Stockholm, November 16th, 2017 – Attana AB, Karolinska Universitetssjukhuset and KTH, Royal Institute of Technology has been granted 4.8 MSEK from the Vinnova program supporting R&D of biological drugs. The grant is used for development of bispecific antibodies targeting leukemia and hematopetic stemcells.The project aims at developing bispecific antibodies targeting stem cells and leukaemia cells. To optimise the antibodies Attana´s cell based biosensor combined with a newly developed immunological technology at KTH. This will provide information about contact dynamics and kinetics, immune

Hiddn Solutions ASA – Successfully completed private placement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement published by Hiddn Solutions ASA ("Hiddn" or the "Company") earlier today, 16 November 2017, regarding a contemplated private placement (the "Private Placement") of new shares (the "New Shares") in the

PAYDAY 2 VR Beta Starts Now!

MEDIA BLAST Starbreeze Studios and OVERKILL - A Starbreeze Studio just announced the start of the highly anticipated beta for PAYDAY 2 VR in the HTC Vive™ on Steam. Available immediately, all owners of any edition of PAYDAY 2™ and its respective DLC’s will be able to participate in the beta. PAYDAY 2 VR will allow players to cross-play with their friends on a standard desktop PC. Desktop PC Heisters wanting to join their VR crew can simply participate by downloading the beta branch. The beta will be on-going and is aimed to test several aspects of the VR version of the game

Advania Iceland receives NCR Partner Awards for Excellence

The American hardware, software, and electronics company NCR Corporation awarded Advania the NCR Partner Awards for Excellence at an annual conference in Barcelona in October, where NCR met with their partners in Europe, Middle-East, and Africa.  Ívar Logi Sigurbergsson, sales manager at Advania, and Daði Snær Skúlason, product manager at Advania, accepted the award on behalf of Advania. NCR is a global leader that has been servicing the bank and retail industry since 1884 in over 120 countires. The company has developed software solutions and sales and handling equipment such as self-

New members of Scandi Standard’s nomination committee

Scandi Standard AB’s (publ) nomination committee has in accordance with the instruction that was adopted at the annual general meeting on 25 April 2017 informed the company of its new composition. For the time until new members are appointed or a member resigns, the nomination committee consists of the following members: · Gustav Lindner (chairman, appointed by Investment AB Öresund); · Justin Carton (appointed by Carton Group); · Hans Hedström (appointed by Carnegie Fonder); · Ulf Zenk (appointed by Lantmännen Animalieinvest AB); and · Per Harkjaer (chairman of the board

Catena Media presents new ambitious financial targets

The Board of Catena Media plc has resolved on new financial targets for the company in the short to medium term.Growth and earnings  Catena Media has a target to reach an EBITDA in excess of EUR 100 million in 2020, driven by annual double-digit percentage organic revenue growth and acquisitions.    Leverage  Catena Media’s short to medium term goal is to operate with Net Debt / EBITDA* in the range 1.5-2.5x. The company may elect to operate temporarily outside this span under certain circumstances and during limited time periods. Dividend  Catena Media does not intend to

Hiddn Solutions ASA - Contemplated private placement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Hiddn Solutions ASA (“Hiddn” or the “Company”) is contemplating a private placement of up to NOK 15 million to strengthen its balance sheet, finance working capital and for general corporate purposes.  Hiddn has for some time been in discussions with a

There are no items matching the current filter
There are no more items matching the current filter
Back to top